首页> 外文期刊>International Journal of Pharmaceutics >A highly sustainable and versatile granulation method of nanodrugs via their electrostatic adsorption onto chitosan microparticles as the granulation substrates.
【24h】

A highly sustainable and versatile granulation method of nanodrugs via their electrostatic adsorption onto chitosan microparticles as the granulation substrates.

机译:通过将纳米药物静电吸附到作为制粒基质的壳聚糖微粒上,这是一种高度可持续且用途广泛的制粒方法。

获取原文
获取原文并翻译 | 示例
           

摘要

Nanodrugs play important roles in enhancing the sustainability of pharmaceutical manufacturing via their ability to enhance the bioavailability of poorly soluble drugs, resulting in less drug wastage and less mass/energy consumed in their manufacturing. Despite their sustainability enhancement capability, solid dosage form manufacturing of nanodrugs remains lacking from the sustainability perspective. One example is the granulation of nanodrugs prior to tablet preparation, where existing methods (e.g. wet granulation, spray granulation, spray drying) require high energy and time expenses, or are highly intricate often leading to product inconsistencies. Herein we present an alternative nanodrug granulation method via electrostatic adsorption of the nanodrugs onto chitosan microparticles acting as granulation substrates. The method is sustainable involving only mixing of aqueous suspensions of the nanodrugs and substrates under ambient conditions, followed by washing and drying. We investigate the effects of substrate's physical characteristics and nanodrug to substrate ratio on the nanodrug loading in the granules, content uniformity, nanodrug recovery, and granule flowability. Ciprofloxacin and curcumin nanoplexes prepared by drug-polyelectrolyte complexation are used as the model nanodrugs with neutrally, positively, and negatively charged chitosan microparticles as the substrates. Granules having 25% (w/w) nanodrug loading at 50% (w/w) recovery with good flowability have been successfully prepared.
机译:纳米药物通过增强难溶性药物的生物利用度的能力,在增强药物制造的可持续性方面发挥重要作用,从而减少了药物浪费,并减少了其制造过程中消耗的质量/能量。尽管具有可持续性增强能力,但从可持续性的角度来看,仍缺乏纳米药物的固体剂型生产。一个例子是在制备片剂之前将纳米药物制粒,其中现有方法(例如湿法制粒,喷雾制粒,喷雾干燥)需要高能量和时间费用,或者过于复杂常常导致产品不一致。本文中,我们通过将纳米药物静电吸附到充当制粒基质的壳聚糖微粒上,提出了一种替代的纳米药物制粒方法。该方法是可持续的,包括仅在环境条件下混合纳米药物和基质的水性悬浮液,然后洗涤和干燥。我们研究了底物的物理特性和纳米药物与底物的比例对颗粒中纳米药物负载量,含量均匀性,纳米药物回收率和颗粒流动性的影响。通过药物-聚电解质络合制备的环丙沙星和姜黄素纳米复合物被用作模型纳米药物,以中性,带正电和带负电的壳聚糖微粒为底物。已成功制备了具有25%(w / w)纳米药物负载量,回收率50%(w / w)和良好流动性的颗粒。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号